Monoclonal Antibody Treatment FAQ’s

Share

MainStreet Family Care and KidsStreet Urgent Care will soon be offering COVID-19 monoclonal antibody treatments. These are for mild to moderate COVID-19 cases and for people at high risk of disease progression. The FDA has issued EUAs for two investigational monoclonal antibodies that can attach to parts of the virus. As a result, these could help the immune system recognize and respond more effectively to the virus. These treatments will only be offered at certain locations.

Which MainStreet and KidsStreet locations are offering this treatment?

Currently the Pelham, Alabama, location is the only location offering this treatment. Please check back soon. This information will change as we begin providing treatments at other locations. Please continue reading to learn more about eligibility and how to schedule an appointment.

How do I know if I’m eligible to receive this treatment?

For example, let’s say you receive a positive test result for COVID-19. If you are someone who is more likely to get very sick from COVID-19, your healthcare provider may recommend this treatment. In order to qualify for treatment, the patient must weigh at least 88 lbs and meet the following criteria for their age group. Click below to see who meets the criteria.

Monoclonal Antibody IV Treatment Criteria

Who is the manufacturer and is it FDA authorized?

We currently offer two treatments. Patients will be given either the Regeneron or Eli Lilly’s monoclonal antibody treatment. Eligible patients will receive whichever one of these are available and in-clinic at the time of treatment.

Again, these treatments are for patients with mild to moderate cases of COVID-19. You must meet the eligibility requirements and be within 10 days of the onset of symptoms. While results may vary, and as with everything COVID-related, initial reports are positive. In fact, some reports show that receiving this treatment can reduce hospitalization by up to 70% for those eligible to receive it. You can read more here on the CDC’s website.

Eli Lilly Monoclonal Antibody Treatment

  • The drug used in the Eli Lilly monoclonal antibody treatment is called bamlanivimab.
  • This is a monoclonal antibody. It is specifically directed against the spike protein of SARS-CoV-2, designed to block the virus’ attachment and entry into human cells.
  • It has FDA authorization. You can find that information at fda.gov by clicking here.
  • In order to qualify for treatment, the patient must weigh at least 88 lbs and meet the following criteria for their age group. Click below to see who meets the criteria.

Treatment Criteria

Regeneron Monoclonal Antibody Treatment

  • The Regeneron monoclonal antibody treatment is a combination of the drugs are called casirivimab and imdevimab.
  • These are monoclonal antibodies. They are specifically directed against the spike protein of SARS-CoV-2, designed to block the virus’ attachment and entry into human cells.
  • Regeneron has FDA authorization. You can find that information at fda.gov by clicking here.
  • In order to qualify for treatment, the patient must weigh at least 88 lbs and meet the following criteria for their age group. Click below to see who meets the criteria.

Treatment Criteria

How do I get this COVID-19 treatment?

If you test positive at any of our locations, and you are eligible for treatment, you can receive treatment at clinics where treatment is available. We are only able to provide a limited number of treatments per day. If you believe you are eligible, please fill out the interest form at the bottom of the page to secure a visit with a provider regarding treatment.

In order to qualify for treatment, the patient must weigh at least 88 lbs and meet the following criteria for their age group. Click below to see who meets the criteria.

Treatment Criteria

Do I get this treatment through an IV?

Yes. The entire process, not including wait time at home or at the clinic, takes approximately 2 hours. First, we administer the COVID-19 monoclonal antibody treatment through an IV. This process takes approximately 1 hour. During this process, patients will be periodically monitored. After we administer the medication through the IV, patients are required to stay inside the clinic for 1 additional hour. This is for additional monitoring by clinic staff prior to your discharge.

What if I have a positive COVID-19 diagnosis from another medical facility? Can you still treat me?

We can as long as you meet the eligibility requirements, bring a copy of your positive test results, and we have the medication available. In addition, all recipients of this monoclonal antibody treatment must receive it within 10 days of the onset of COVID-19 symptoms.

Will my insurance cover this treatment? What if I am uninsured? What is the cost?

The government pays for the treatment drug. However, as with anything medical, there are many aspects.  A clinic visit to get monoclonal antibody treatment typically has three parts:  (1) The co-pay for the office visit, (2) the cost of the office visit, (3) the cost of the medication.

Uninsured Patients

We are excited to participate in a program launched by the Department of Human Health Services (HHS). This program reimburses healthcare providers and laboratories for providing COVID-19 testing and treatment to uninsured patients. As a result, this allows us to extend COVID-19 testing, treatment, and vaccinations to patients without insurance. This will continue as long as program funding continues to be available. You can learn more about this program here.

Simple Self-Pay

We are proud to offer a simple self-pay option of $125. The government pays for the medication itself. The cost of the office visit, administration of the drug, and the supplies are all included in the simple self-pay fee of $125. In other words, this includes all in-clinic labs and procedures you will need within a single visit. If you have additional questions about our self-pay options, please contact us.

Medicaid Patients

We don’t currently have information regarding Medicaid coverage. However, we will provide that information here once it is available.

Insured Patients

Co-Pays

We are currently waiving co-pays for COVID-19 monoclonal antibody treatments as well as COVID-19 testing.

Office Visits

During your office visit, eligibility will be determined. Some patients may be symptomatic or at risk. As a result, additional tests and evaluations may be performed in the clinic. Different insurance providers deal with these in different ways.  Sometimes they make you pay toward your deducible for these.  In these cases, you may get a bill from MainStreet for aspects of the office visit that were not the monoclonal antibody treatment.

The Medication

The government pays for the treatment drug. MainStreet administers the drug and provides the office visit and supplies. We will bill these to your insurance company. Subsequently, your insurance company may require you to pay some or all of that portion of the treatment.

In summary, the government pays for the drug treatment itself. However, in order to get the treatment, other services may be performed that the insurance company wants you to pay for.

Do I need to be tested for COVID-19 again or schedule a follow-up visit?

No, we don’t require a follow-up visit or re-testing for COVID-19 after your treatment. If your employer requires a re-test to return to work, please ask the provider during your visit when you should return.

I would like to receive the monoclonal antibody IV treatment for COVID-19.

Are you interested in receiving this treatment? If you recently tested positive for COVID-19, please ensure you meet the following guidelines and fill out the interest form below. In other words, this form lets us know you are interested in treatment. It does not guarantee that you will receive treatment. Please submit the form below. As a result, a member of our team will contact you within 24 hours. Our team will be scheduling appointments based on eligibility and availability.

Monoclonal Antibody Treatment - Interest Form
PLEASE NOTE: This treatment is currently only being offered at the MainStreet and KidsStreet location in Pelham, Alabama.
Full name as it appears on driver's license or birth certificate.
If patient is under 18 years old.

COVID Testing Information

This information should be on your positive result paper.

Eligibility Information